BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 10, 2019
View Archived Issues
BAY-218, a first-in-class AhR antagonist for overcoming tumor-mediated immunosuppression
Read More
How CMV blocks immune recognition
Read More
New bromophenol derivatives as specific PTP1B inhibitors for the treatment of type 2 diabetes
Read More
Mechanism underlying youthful and aging skin found in mice
Read More
Patient enrollment ongoing in phase I study of LYN-00101
Read More
First-in-human data for PLN-74809 support development of the candidate for the treatment of IPF
Read More
First patient enrolled in phase I/II study of NanoDoce for the treatment of bladder cancer
Read More
Enesi Pharma and Oxford Vaccine Group to develop plague vaccine
Read More
Researchers present new oncolytic adenovirus shRNA-based immunotherapy strategy
Read More
A*STAR describes new isoprenylcysteine carboxylmethyltransferase inhibitors
Read More
ImmuneOnco Biopharma reports discovery of novel bispecific antibody-trap, IMM-0306
Read More
Preclinical data presented for a novel cross-linking dependent 4-1BB agonist antibody, PE-0116
Read More
Next-generation of HBV CAMs presented
Read More
Zhejiang Hisun Pharmaceutical discloses mutant c-Kit/PDGFR-alpha inhibitors
Read More
New TLR7 agonists patented by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical
Read More
University of Nottingham presents CDK12/cyclin K inhibitors
Read More
Protein-arginine deiminase type-4 inhibitors discovered at Jubilant Biosys
Read More
U.S. approval for Evenity for osteoporosis in postmenopausal women at high risk for fracture
Read More
European Commission approves Lynparza for germline BRCA-mutated HER-negative advanced breast cancer
Read More
Discovery and characterization of selective AMPAR/gamma-8 negative modulators as antiepileptics
Read More
Results of phase I trial of RNA-based adjuvant CV-8102 combined with a licensed rabies vaccine
Read More
DNA-encoded monoclonal antibody prevents Zika infection in mice and nonhuman primates
Read More
GHIT Fund grant supports further development of asexual blood-stage malaria vaccine candidate
Read More
Dual kappa/delta-opioid agonist CA-1001 shows efficacy in pain models
Read More
PharmaMar announces new immuno-oncology program
Read More
